Mr. Lowrance has served as Savara’s Chief Financial and Administrative Officer since December 2022 and Chief Financial Officer since November 2016. Previously, Mr. Lowrance was the Chief Financial Officer and Treasurer of Edgemont Pharmaceuticals, a fully integrated specialty pharmaceutical company. Prior to that, Mr. Lowrance served as the Chief Financial Officer and Secretary of Acucela Inc., a clinical-stage biotechnology company, where he was responsible for overseeing all aspects of the day-to-day operations, business development and growth endeavors, investor relations, and corporate communications. While there, Mr. Lowrance helped lead a $162 million international IPO, with a listing on the Tokyo Stock Exchange. Earlier in his career, Mr. Lowrance was Vice President and Chief Financial Officer of Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, where he oversaw all aspects of finance and accounting, business and growth strategy, and product development. Mr. Lowrance holds a CPA and has a B.B.A. in Accounting from the University of Georgia.